Awakn Life Sciences Corp.
AWKNF
$0.065
-$0.0147-18.44%
OTC PK
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -275.50K | -263.60K | -401.50K | -691.70K | -476.60K |
| Total Depreciation and Amortization | 3.30K | 3.40K | 3.50K | 3.50K | 4.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 20.00K | 24.40K | 27.20K | 97.30K | 74.00K |
| Change in Net Operating Assets | -183.40K | 238.30K | 1.40K | 517.30K | -84.30K |
| Cash from Operations | -435.70K | 2.50K | -369.40K | -73.60K | -482.30K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -45.00K | 0.00 |
| Other Investing Activities | -- | -- | -- | 45.00K | 0.00 |
| Cash from Investing | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 392.30K | 590.90K | 195.70K | -- | 764.70K |
| Repurchase of Common Stock | -- | -- | -- | -78.70K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 45.70K | 0.00 |
| Cash from Financing | 287.30K | 431.60K | 144.20K | -24.40K | 563.10K |
| Foreign Exchange rate Adjustments | -3.10K | -1.70K | 14.00K | -11.10K | 11.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -151.50K | 432.30K | -211.20K | -109.10K | 92.00K |